In recent trading session, Recursion Pharmaceuticals Inc (NASDAQ:RXRX) saw 0.7 million shares changing hands at last check today with its beta currently measuring 0.81. Company’s recent per share price level of $7.09 trading at $0.2 or 2.98% at last check today assigns it a market valuation of $2.04B. That most recent trading price of RXRX’s stock is at a discount of -122.0% from its 52-week high price of $15.74 and is indicating a premium of 29.9% from its 52-week low price of $4.97. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 5.19 million shares which gives us an average trading volume of 5.75 million if we extend that period to 3-months.
For Recursion Pharmaceuticals Inc (RXRX), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 2.50. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.35 in the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Recursion Pharmaceuticals Inc (NASDAQ:RXRX) trade information
Upright in the green today for gaining 2.98%, in the last five days RXRX remained trading in the green while hitting it’s week-highest on Thursday, 09/26/24 when the stock touched $7.09 price level, adding 0.7% to its value on the day. Recursion Pharmaceuticals Inc’s shares saw a change of -28.04% in year-to-date performance and have moved 2.23% in past 5-day. Recursion Pharmaceuticals Inc (NASDAQ:RXRX) showed a performance of -6.77% in past 30-days. Number of shares sold short was 59.16 million shares which calculate 12.37 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 11 to the stock, which implies a rise of 35.55% to its recent value today. Analysts have been projecting 6 as a low price target for the stock while placing it at a high target of 12. It follows that stock’s current price would jump 15.37% in reaching the projected high whereas dropping to the targeted low would mean a gain of 15.37% for stock’s current value.
Recursion Pharmaceuticals Inc (RXRX) estimates and forecasts
Statistics highlight that Recursion Pharmaceuticals Inc is scoring comparatively lower than the scores of other players of the relevant industry. The company lost -30.24% of value to its shares in past 6 months, showing an annual growth rate of 0.00% while that of industry is 20.80. This year revenue growth is estimated to rise 55.20% from the last financial year’s standing.
7 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 30.04M for the same. And 7 analysts are in estimates of company making revenue of 14.67M in the next quarter. Company posted 10.53M and 10.89M of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -43.41% during past 5 years. In 2024, company’s earnings growth rate is likely to be around 1.11% while estimates for its earnings growth in next 5 years are of 12.00%.
Recursion Pharmaceuticals Inc (NASDAQ:RXRX)’s Major holders
Insiders are in possession of 4.55% of company’s total shares while institution are holding 89.78 percent of that, with stock having share float percentage of 94.07%. Investors also watch the number of corporate investors in a company very closely, which is 89.78% institutions for Recursion Pharmaceuticals Inc that are currently holding shares of the company. ARK INVESTMENT MANAGEMENT LLC is the top institutional holder at RXRX for having 28.14 million shares of worth $211.07 million. And as of 2024-06-30, it was holding 11.924 of the company’s outstanding shares.
The second largest institutional holder is BAILLIE GIFFORD & CO, which was holding about 26.59 million shares on 2024-06-30. The number of shares represents firm’s hold over 11.266 of outstanding shares, having a total worth of $199.42 million.
